Intellectual Property News & Topics - Secerna LLP

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more

Antibodies_Testing_Image

News 04/07/2023

Assessing Inventive Step of Antibodies at the European Patent Office

B012853

Team news, Careers 20/06/2023

Grace Holliday in profile

Dermot GB2 1498 Nov 22

Events 18/06/2023

Secerna to attend Dublin IP and R&D Summit

Secerna Header Images (3)

Events, News 12/06/2023

Secerna LLP to attend BioFocus 2023 in Newcastle

GB2 4127

Industry news, News, Team news 08/06/2023

Secerna appoints marketing lead to fuel growth

EU Flag UPC article

European, Industry news, News 01/06/2023

New era for European patent law as unified patent system takes effect

AI Image Secerna LLP

Industry news, News 23/05/2023

The UK and the EU: Taking different approaches to AI regulation

Dermot GB2 1498 Nov 22

Events 22/05/2023

Secerna to attend Dublin Tech Summit 2023

B012424

Events 19/05/2023

Secerna to attend Nu-Tech Engineering & Technology Solutions Exhibition

15 16 17 18 19 20 21 22 23 24 25